Autologous stem cell transplant in fit patients with refractory or early relapsed diffuse large B-cell lymphoma that responded to salvage chemotherapy.

Autor: Tun AM; Division of Hematology, Mayo Clinic, Rochester, Minnesota; Division of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas, Kansas City. atun@kumc.edu., Wang Y; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Maliske S; Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, Iowa., Micallef I; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Inwards DJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Habermann TM; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Porrata L; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Paludo J; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Bisneto JV; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Rosenthal A; Internal Medicine, Division of Hematology/Oncology, Mayo Clinic Arizona, Scottsdale, Arizona., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida., Ansell SM; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Nowakowski GS; Division of Hematology, Mayo Clinic, Rochester, Minnesota., Farooq U; Division of Hematology, Oncology, and Blood and Marrow Transplantation, University of Iowa, Iowa City, Iowa., Johnston PB; Division of Hematology, Mayo Clinic, Rochester, Minnesota.

Publikováno v: Haematologica [Haematologica] 2024 Jul 01; Vol. 109 (7), pp. 2186-2195. Date of Electronic Publication: 2024 Jul 01.

Central nervous system involvement by mantle cell lymphoma.

Autor: McLaughlin N; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA., Wang Y; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Witzig T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Villasboas J; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Habermann T; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Inwards D; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Bennani N; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Thanarajasingam G; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Nowakowski G; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Porrata L; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Thompson C; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Micallef I; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Johnston P; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Ansell S; Division of Hematology, Mayo Clinic, Rochester, MN, USA., Paludo J; Division of Hematology, Mayo Clinic, Rochester, MN, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 371-377. Date of Electronic Publication: 2022 Nov 23.

Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.

Autor: Iqbal M; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL. Electronic address: iqbal.madiha@mayo.edu., Castano YG; St. Barnabas Hospital, Bronx, NY., Paludo J; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Rosenthal A; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ., Li Z; Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL., Beltran M; St. Barnabas Hospital, Bronx, NY., Moustafa MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Inwards D; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Porrata L; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Micallef I; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Bisneto JCV; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Johnston P; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Ansell SM; Division of Hematology-Oncology, Mayo Clinic, Rochester, MN., Reeder C; Division of Hematology-Oncology, Mayo Clinic, Phoenix, AZ., Murthy H; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Roy V; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Foran J; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Tun HW; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Kharfan-Dabaja MA; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL., Ayala E; Division of Hematology-Oncology and Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL.

Publikováno v: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2022 Feb; Vol. 22 (2), pp. e89-e95. Date of Electronic Publication: 2021 Aug 31.

Day 100 Recovery of Absolute Number of Inhibitory KIR2DL2 and Activating NKp30 Natural Killer Cells Predicts Survival Post-Autologous Stem Cell Transplantation in Lymphomas.

Autor: Porrata, Luis F., Ansell, Stephen M., Micallef, Ivana N., Johnston, Patrick B., Villasboas, Jose C., Paludo, Jonas, Durani, Urshila, Markovic, Svetomir N.

Publikováno v: Biomedicines; Aug2024, Vol. 12 Issue 8, p1808, 12p

Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma.

Autor: Joao, C.^1,2, Porrata, L. F.² porrata.luis@mayo.edu, Inwards, D. J.², Ansell, S. M.², Micallef, I. N.², Johnston, P. B.², Gastineau, D. A.², Markovic, S. N.²

Publikováno v: Bone Marrow Transplantation. May2006, Vol. 37 Issue 9, p865-871. 7p. 2 Diagrams, 3 Charts.